|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Akebia Therapeutics (NASDAQ: AKBA) through any online brokerage.
The latest price target for Akebia Therapeutics (NASDAQ: AKBA) was reported by Cantor Fitzgerald on March 8, 2021. The analyst firm set a price target for 8.00 expecting AKBA to rise to within 12 months (a possible 117.39% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Akebia Therapeutics (NASDAQ: AKBA) is $3.68 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Akebia Therapeutics.
There is no upcoming split for Akebia Therapeutics.
Akebia Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.